Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
Protein kinases are involved in many essential cellular processes and their deregulation can lead to a variety of diseases, including cancer. The pharmaceutical industry has invested heavily in the identification of kinase inhibitors to modulate these disease-promoting pathways, resulting in several...
Main Authors: | , , |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
Future Science
2014
|
_version_ | 1826258609295589376 |
---|---|
author | Cowan-Jacob, S Jahnke, W Knapp, S |
author_facet | Cowan-Jacob, S Jahnke, W Knapp, S |
author_sort | Cowan-Jacob, S |
collection | OXFORD |
description | Protein kinases are involved in many essential cellular processes and their deregulation can lead to a variety of diseases, including cancer. The pharmaceutical industry has invested heavily in the identification of kinase inhibitors to modulate these disease-promoting pathways, resulting in several successful drugs. However, the field is challenging as it is difficult to identify novel selective inhibitors with good pharmacokinetic/pharmacodynamic properties. In addition, resistance to kinase inhibitor treatment frequently arises. The identification of non-ATP site targeting ('allosteric') inhibitors, the identification of kinase activators and the expansion of kinase target space to include the less studied members of the family, including atypical- and pseudo-kinases, are potential avenues to overcome these challenges. In this perspective, the opportunities and challenges of following these approaches and others will be discussed. |
first_indexed | 2024-03-06T18:36:40Z |
format | Journal article |
id | oxford-uuid:0b7ace66-6e5c-4b4e-b8c4-d069c308eb2c |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:36:40Z |
publishDate | 2014 |
publisher | Future Science |
record_format | dspace |
spelling | oxford-uuid:0b7ace66-6e5c-4b4e-b8c4-d069c308eb2c2022-03-26T09:29:35ZNovel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0b7ace66-6e5c-4b4e-b8c4-d069c308eb2cEnglishSymplectic Elements at OxfordFuture Science2014Cowan-Jacob, SJahnke, WKnapp, SProtein kinases are involved in many essential cellular processes and their deregulation can lead to a variety of diseases, including cancer. The pharmaceutical industry has invested heavily in the identification of kinase inhibitors to modulate these disease-promoting pathways, resulting in several successful drugs. However, the field is challenging as it is difficult to identify novel selective inhibitors with good pharmacokinetic/pharmacodynamic properties. In addition, resistance to kinase inhibitor treatment frequently arises. The identification of non-ATP site targeting ('allosteric') inhibitors, the identification of kinase activators and the expansion of kinase target space to include the less studied members of the family, including atypical- and pseudo-kinases, are potential avenues to overcome these challenges. In this perspective, the opportunities and challenges of following these approaches and others will be discussed. |
spellingShingle | Cowan-Jacob, S Jahnke, W Knapp, S Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. |
title | Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. |
title_full | Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. |
title_fullStr | Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. |
title_full_unstemmed | Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. |
title_short | Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. |
title_sort | novel approaches for targeting kinases allosteric inhibition allosteric activation and pseudokinases |
work_keys_str_mv | AT cowanjacobs novelapproachesfortargetingkinasesallostericinhibitionallostericactivationandpseudokinases AT jahnkew novelapproachesfortargetingkinasesallostericinhibitionallostericactivationandpseudokinases AT knapps novelapproachesfortargetingkinasesallostericinhibitionallostericactivationandpseudokinases |